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All strains of Bifidobacterium animalis subsp. lactis described to date show medium level resistance to
tetracycline. Screening of 26 strains from a variety of sources revealed the presence of tet(W) in all isolates. A
transposase gene upstream of tet(W) was found in all strains, and both genes were cotranscribed in strain
IPLAIC4. Mutants with increased tetracycline resistance as well as tetracycline-sensitive mutants of IPLAIC4
were isolated and genetically characterized. The native tet(W) gene was able to restore the resistance phenotype
to a mutant with an alteration in tet(W) by functional complementation, indicating that tet(W) is necessary and
sufficient for the tetracycline resistance seen in B. animalis subsp. lactis.
Bifidobacteria are common microorganisms in the gastroin-
testinal tracts of humans. The intestine of healthy newborns is
quickly colonized by bifidobacteria, especially those fed with
breast milk, in which they could represent the majority of the
total culturable population, typically remaining dominant until
weaning (7, 12). In adults, however, the intestinal bifidobacte-
rial population is more variable, although it still constitutes one
of the predominant members (29).
Different strains of the genus Bifidobacterium are considered
health-promoting microorganisms for humans. Among them,
Bifidobacterium animalis subsp. lactis is the most common spe-
cies included in functional food products (9, 17, 27), and sev-
eral beneficial effects, such as reduction of the risk of diarrhea
in children and allergy relief, have been attributed to this
bacterium (27).
Due to the ubiquity of B. animalis subsp. lactis in foods and
dietary supplements, the presence of antibiotic resistance de-
terminants in this bacterium is of key interest, since gut com-
mensals possessing an antibiotic resistance gene could theoret-
ically serve as a reservoir of resistance for intestinal pathogens
via horizontal gene transfer. In this regard, resistance to tetra-
cycline has recently been reported as the most common anti-
biotic resistance in bifidobacteria (1, 3, 4, 8, 18), although one
incidence of erythromycin resistance related to the presence of
a transposon-associated erm(X) gene has also been described
previously (32). The most abundant genetic determinants re-
sponsible for the tetracycline resistance phenotype among the
species of this genus are tet genes coding for ribosomal pro-
tection proteins (24). The genes tet(O), tet(M), and tet(W) and
different hybrid determinants [i.e., tet(W/32/O) and tet(O/W)]
were detected in bifidobacteria, tet(W) being the most com-
monly found (1, 4, 15, 19, 31). Remarkably, tet(W) was also
found in Lactobacillus, Clostridium, and other gut bacteria,
thus suggesting a wide distribution among bacteria from the
mammalian gut (5, 13, 22, 23, 28). In this context, the aim of
our research was to investigate the ubiquity of tet(W) among B.
animalis subsp. lactis strains isolated from different origins and
the influence of gastrointestinal conditions on the antibiotic
resistance phenotype and to supply the basis for a correlation
between genotype and phenotype.
The presence of tet(W) in 26 strains of B. animalis subsp.
lactis from a variety of sources, including functional foods,
probiotic supplements, dairy cultures, human feces, and cul-
ture collections, was investigated using microarray analysis and
PCR. Furthermore, their tetracycline resistance levels were
determined using a microdilution method. Briefly, individual
colonies on agar plates were suspended in sterile saline until
a density corresponding to McFarland standard of 1 was
reached. The inoculated suspension was then diluted 1,000-
fold in lactic acid bacterial susceptibility test medium (LSM)
plus cysteine (90% Iso-Sensitest [IST] broth [Oxoid] plus 10%
MRS broth [Oxoid] plus 0.3 g/liter cysteine hydrochloride
[Sigma] [16]) containing the appropriate tetracycline concen-
tration, and 100 l of the diluted bacterial suspension was
added to each well. Incubations were carried out at 37°C for
48 h in a Mac 500 anaerobic chamber (Don Whitley Scientific)
in an atmosphere of 80% N2, 10% H2, and 10% CO2. All the
strains displayed a medium level resistance to the antibiotic,
close to, or above, reference breakpoints described for this
genus (Table 1), suggesting the presence of specific tetracy-
cline resistance determinants (18, 33). The microarray analysis
of 24 out of the 26 strains (Table 1) was carried out as previ-
ously described (19, 30) with in-house printed DNA chips
containing 223 oligonucleotides (50 to 60 nucleotides long),
which represent over 430 antibiotic resistance genes, including
2 otr and 31 tet genes. The results showed, in all cases, positive
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hybridization signals for the oligonucleotides representing
tet(W). Except for the signals with the species-specific control
probes (two 60-mer oligonucleotides designed on conserved
parts of the 16S rRNA [5-gtaacggtggaatgtgtagatatcgggaagaac
accDatggcgaaggcagDtctctgggc-3] and tuf [5-gccgtcactcgccSttc
ttctcSaactaccgtccgcagttctacttccgYaccaccgacg-3] gene se-
quences, respectively, of the genus Bifidobacterium (where D is
A, G, or T, S is C or G, and Y is C or T), no other hybridization
signals were found with any of the remaining spots, indicating
the absence of other antibiotic resistance determinants tested
for with this microarray. Subsequently, PCR primers were de-
signed based on a 3,696-bp fragment of the chromosomal DNA
of B. animalis subsp. lactis IPLAIC4 (GenBank accession num-
ber GU361625) (Table 2 and Fig. 1).
In IPLAIC4, tet(W) is flanked upstream by a putative trans-
posase gene (trp). Primers were designed in a way that allowed
us to amplify the trp gene together with the 5 end of tet(W).
Thus, a positive 1.47-kb amplicon implies that both genes are
organized as they are in IPLAIC4 (Fig. 1). PCRs were carried
out according to standard procedures (4). Positive Trp and Tet
amplicons were obtained for the 26 strains. Afterwards, 10 Trp
and 10 Tet amplicons (from strains IPLA4549, IPLAIC1,
A8dOx, M6, PBT, Y1, Class11, Essen2, A12, and C64) (Table
1) were selected for sequencing (Secugen S.L., Madrid, Spain)
in both directions with the primer pairs TrpF/TrpR and TetF/
TetR, and they all gave homology with the corresponding se-
quences of IPLAIC4. This suggests that the structural organi-
zations of trp and tet(W) are very similar, if not identical, in all
our strains. Transposases catalyze the movement of DNA be-
tween different locations by recognizing insertion sequences in
the DNA and could be involved in the mobilization of tet genes
in bifidobacteria. In fact, one chromosomal tet(W) gene has
been shown to transfer, at low frequency, from Bifidobacterium
longum to Bifidobacterium adolescentis in vitro, and the site of
chromosomal insertion in B. adolescentis is identical to that of
the donor strain, consistent with a transposase-mediated site-
site specific insertion event (13). This suggests that trp could
have been involved in the acquisition of tet(W) by B. animalis
and opens the question of whether trp could participate in the
transfer of tet(W) to other bacteria.
The ability of IPLAIC4 to transfer tet(W) to other bacteria
was tested by filter mating on glucose M17 or MRS (both
supplied by Difco) plates containing cysteine (Sigma) under
anaerobic conditions essentially as previously described (26).
Recipient strains included Lactococcus lactis MG1614 (resis-
tant to rifampin and streptomycin; 2 experiments), Bifidobac-
TABLE 1. Strains analyzed for tetracycline resistance, tetracycline MICs, and detection of the genes tet(W) and
trp by PCR and microarray analysis
Straina Source or reference
Resultb by:
MIC (g/ml)
Microarrayc trp PCR tet(W) PCR
IPLA4549 25    16
4549dOx 25    16
4549dCo 11 ND   16
IPLAIC1 Dairy culture    16
IPLAIC2 IPLAd collection    32
IPLAIC3 IPLA collection    32
A8dOx IPLA collection    8
M6 Fermented milk    16
M6dCo 11    16
PBT Probiotic supplement    16
PBTdOx 11    16
658 Fermented milk    16
658dOx 11    8
LMG11580 Chicken feces    8
LMG18314T Yogurt    16
LMG18906 Rabbit feces    8
KCTC3356 Sewage    32
C64 Human feces    16
CECT4550 Nursling stools ND   32
Y1 Yogurt    16
Class11 Yogurt    8
Essen2 Fermented milk    8
Dia8 Fermented milk    8
BBI Fermented milk    16
A12 Dairy starter    32
IPLAIC4 Fermented milk    16
T25 IPLAIC4 Tetr mutant ND   64
IC4-8658 IPLAIC4 Tetr mutant ND   128
IC4-9991 IPLAIC4 Tets mutant ND   4
IC4-8902 IPLAIC4 Tets mutant ND   1
IC4-8902  pAM1 1
IC4-8902  pAM-TB 32
a IPLAIC4 and mutants derived thereof are in boldface. T, type strain.
b  indicates a positive signal in the microarray or the presence of the right amplicon. ND, not determined.
c The microarray data displayed are the positive hybridization results with the two oligonucleotides representing tet(W) (30).
d IPLA, Instituto de Productos La´cteos de Asturias.
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terium bifidum CHCC2185 (resistant to trimethoprim; 4 exper-
iments), Enterococcus faecalis JH2-2 (resistant to rifampin,
fusidic acid, and erythromycin; 1 experiment), and mutants of
B. animalis subsp. animalis ATCC 25527 and ATCC 27672
resistant to both rifampin and fusidic acid (2 experiments).
Donors, recipients, and transconjugants were quantitated on
plates supplemented with appropriate antibiotics. No transfer
of tet(W) to any recipient was detected, indicating that the
frequency of transfer is less than 109/recipient (data not
shown). The lack of transfer of tet(W) from another B. animalis
subsp. lactis strain has been previously described (18). How-
ever, the experimental conditions used do not represent the
complex in vivo situation in the gut, and the gastrointestinal
environment most likely will offer different conditions for an-
tibiotic resistance transfer than those provided in vitro.
It is important to remark that a similar genetic context in B.
animalis E43 was described previously (4), and an identical
3,696-bp fragment is present in the chromosomes of two re-
TABLE 2. Primers and plasmids used in this study
Plasmid or primer Characteristicsb Reference or source
Plasmids
pAM1 E. coli-Bifidobacterium shuttle cloning vector; Apr Emr 2
pAM-TB pAM1 containing the 3.65-kb fragment cloned in the XbaI site; in this construct, the 5 end of
tet(W) is located beside the PstI site
This work
Cloning primers
TTF GCCGACTCTAGACTTCAATCCTTTTATCAGAGCATCGC; forward cloning primer for
pAM1, XbaI site
This work




TrpF ATTCAGCGACGAACTGGCACAG; forward primer for trp-tet(W) amplification This work
TrpR CGCTTGAATGGTAATCCCACG; reverse primer for trp-tet(W) amplification This work
TetF TGGAATTCTTGCCCATGTAGACG; forward primer for tet(W) amplification This work
TetR GAACATATGGCGCACCTTGTCC; reverse primer for tet(W) amplification This work
RT-PCRa primers
qRT-TrpF CGACAGCCGCGCATTT This work
qRT-TrpR CGTTCGGAACCTGGTTGCT This work
qRT-TrpIntF CAGACCCTGTCTGGCAGCTT This work
qRT-TrpIntR TGTGGATAACCTCCGAATTTTTTG This work
qRT-IntF CGGTGTTGCCTTAAATAAAACTATAATCA This work
qRT-IntR GGCAAAAGTATTCTTAAATTGGGTACAA This work
qRT-IntTetF TCATCCCCAGTGGTAAAAGTATTTTACT This work
qRT-IntTetR CATGGGCAAGAATTCCAATATTG This work
qRT-Tet1F GCCCGGCCACATGGAT This work
qRT-Tet1R GCCCCATCTAAAACAGCCAAA This work
a RT-PCR, quantitative reverse transcription-PCR.
b XbaI sites are in italics and underlined.
FIG. 1. Organization of the B. animalis subsp. lactis IPLAIC4 genomic region containing tet(W), trp, and the upstream and downstream regions.
The open arrows indicate the relative positions and directions of transcription of the open reading frames (ORFs). The positions of the primers
used for standard PCR and quantitative PCR analysis are indicated. The locations of the mutations found in the IPLAIC4 mutants T25, IC4-9991,
and IC4-8902 are detailed. The pin-like symbol indicates a Rho-independent transcription terminator. hp, hypothetical protein gene; guaA, GMP
synthase gene. Asterisks indicate identical bases in the compared sequences.
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cently sequenced B. animalis subsp. lactis strains (GenBank
accession numbers CP001606 and CP001515). The strain
AD011 also contains an almost identical DNA fragment,
differing only in 1 base (GenBank accession number
CP001213). The high degree of sequence conservation among
our strains and the 3 currently available genome sequences
indeed supports the results of Barrangou and coworkers (6)
and indicates that this subspecies comprises clonal bacteria
which are genomically monomorphic.
Previous studies indicated that the acquisition of a stable
bile resistance phenotype or the transient exposure to bile
induces an increase in tetracycline resistance in Bifidobacte-
rium (14, 20). We tested if this phenotypic change could be
correlated with the activity of tet(W). For this purpose,
IPLAIC4 was incubated in MRSc broth (MRS [Difco] supple-
mented with 0.05% cysteine [Sigma]) containing 0.8 to 1% bile
(Ox-gall; Oxoid) for 5 consecutive days (5 overnight cultures;
approximately 50 generations). After that, the culture was
plated on MRSc agar containing tetracycline (25, 75, or 125
g/ml; Sigma). Hardly any colony was able to grow on 75 or
125 g/ml, but numerous colonies were recovered on 25 g/ml
tetracycline. Interestingly, the frequency of colonies able to
grow at this concentration was higher for those cultures pre-
viously grown in the presence of bile (one out of 102 to 104
CFU) than for the control culture grown in the absence of bile
(one out of around 105 to 106 CFU). We analyzed 47 colonies
recovered from 25-g/ml tetracycline plates, and most of them
had a transient resistance phenotype (not stable), since they
revert to the original resistance level when grown in the ab-
sence of bile. This could suggest a temporal activation of
tet(W) when bile is present, which is lost when bile is removed.
In fact, quantitative PCR experiments indicated an induction
of tet(W) (from 2- to 4-fold at bile concentrations of 0.25 and
0.75%, respectively) when IPLAIC4 was grown in the presence
of bile. Also, transcriptional analysis of IPLAIC4 using dedi-
cated genomic microarrays indicated a slight induction of
tet(W) (between 1.5- and 2-fold upregulation, tested with 4
different probes) in the presence of 0.1% bile (M. Gueimonde
and C. Garrigues, unpublished data). Only one of the colonies
recovered from the 25-g/ml tetracycline plates was able to
grow consistently in high tetracycline concentrations. This
strain was named T25 and was included in further analyses.
Mutants of IPLAIC4, sensitive to tetracycline, were isolated
following mutagenesis with UV light (2 exposures of 5-min
duration at 70 mJ/cm2) in the presence of ethidium bromide
(20 g/ml) and a subsequent ampicillin enrichment step. IC4-
8902 and IC4-9991 were more sensitive than the original strain
to tetracycline (Table 1). A mutant of IPLAIC4 with elevated
resistance was isolated following subculturing in medium con-
taining increasing concentrations of tetracycline. Mutant IC4-
8658 is resistant to 100 g/ml tetracycline.
A 3.65-kbp fragment (between primers TTF and TTR) (Fig.
1) containing tet(W) was sequenced in these 3 mutants and in
T25 (Fig. 1), rendering valuable information on the potential
genetic differences that lead to distinct tetracycline resistance
levels. The mutant IC4-9991 contains a point mutation in
tet(W) (cytosine 41 is replaced by an adenine). This introduced
a different amino acid at position 14 (A14/D14) in the Walker
A motif of the nucleotide binding domain (21), which could
influence the activity of the protein, although in our case
tet(W) seems to retain some residual activity. In the mutant
IC4-8902 the thymine at position 1406 of tet(W) is missing,
which yields a frameshift and a potentially shorter version of
the protein (468 residues instead of 639), likely nonfunctional.
On the other hand, the 3,696-bp region in the mutant IC4-8658
was 100% identical to the corresponding region in IPLAIC4,
suggesting that the mutation(s) responsible for the high-resis-
tance phenotype is located somewhere outside this region.
Finally, in the mutant T25 we found a duplication of an 8-bp
fragment (TGCCATAT) in the putative promoter (35 re-
gion) of trp which could affect promoter activity.
We determined the expression levels of tet(W) in the differ-
ent mutants grown in MRSc in the presence of tetracycline
(antibiotic concentrations were selected on the basis of similar
levels of growth inhibition among the different strains: 0.4
g/ml for IC4-8902, 1 g/ml for IC4-9991, 38 g/ml for T25
and IC4-8658, and 12 g/ml for IPLAIC4. Quantitative PCR
was carried out as previously described (10) using the primers
qRT-Tet1F and qRT-Tet1R (Table 2 and Fig. 2). Expression
levels were determined by relative quantification using the
CT method, in which the expression level in the control
culture (IPLAIC4) is arbitrarily set to 1 and the expression
levels in the samples are calculated relative to that control.
Experiments were carried out in duplicate, each measured in
duplicate in two independent PCR runs. This experiment in-
deed suggested that the increased tetracycline resistance in
mutants T25 and IC4-8658 is due to an increased expression of
tet(W).
A quantitative reverse transcription-PCR (RT-PCR) analy-
sis was carried out in order to ascertain if trp and tet(W) were
expressed independently or in the same transcript. Primers
were designed in order to amplify internal fragments of the 2
genes (qRT-TrpF/qRT-TrpR and qRT-Tet1F/qRT-Tet1R),
the intergenic region (qRT-IntF/qRT-IntR), the trp 3 end
together with the 5 end of the intergenic region (qRT-
TrpIntF/qRT-TrpIntR), and the 5 end of tet(W) together with
the 3 end of the intergenic region (qRT-IntTetF/qRT-
IntTetR) (Fig. 1 and Table 2). The analysis was carried out
with strains IPLAIC4, T25, and IC4-8902. All primers pro-
duced amplification products for the 5 amplicons in the three
strains. In addition, the five amplified fragments were found to
FIG. 2. Relative expression of tet(W) from IPLAIC4 and mutants
derived thereof, determined by quantitative reverse transcription-
PCR. The expression levels in the presence of subinhibitory tetracy-
cline concentrations for each strain (see text) were normalized to those
obtained for the control culture (IPLAIC4 grown without tetracy-
cline). Expression levels were calculated by using the CT method.
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be present in equal amounts, indicating that trp and tet(W) are
transcribed together as part of a bicistronic operon.
Finally, in order to unequivocally demonstrate that the
tetracycline resistance phenotype in B. animalis subsp. lactis is
conferred by tet(W) and not by other genes present in its
genome, whose function could have passed unnoticed by us, we
cloned the 3.65-kb fragment from IPLAIC4 containing trp and
its upstream region and the native tet(W) gene in the mutant
IC4-8902, in which a truncated, nonfunctional version of
tet(W) is present. The fragment was amplified using Pfx DNA
polymerase (Invitrogen) and the primers TTF and TTR ac-
cording to the manufacturer’s instructions. The PCR product
was digested with XbaI and cloned in the Escherichia coli-
Bifidobacterium shuttle vector pAM1 (2), digested with the
same enzyme, to generate the plasmid pAM-TB. Cloning and
transformation procedures were carried out as previously de-
scribed (2). The IC4-8902 strain containing the empty vector
(pAM1) displayed a tetracycline MIC of 1 g/ml, similar to
that for IC4-8902. However, IC4-8902 harboring pAM-TB
showed a MIC of 32 g/ml, even higher than that for IPLAIC4;
this difference is probably due to the presence of multiple
copies of the tet(W) gene. This result indicates that tetracycline
resistance in B. animalis subsp. lactis is conferred by tet(W) and
suggests that no other genetic determinants participate in this
process.
In summary, this work shows the wide distribution of tet(W)
among B. animalis subsp. lactis strains and its involvement in
the tetracycline resistance phenotype of this bacterium. Bile
exposure slightly induces tet(W) expression, which could influ-
ence resistance levels in certain environments. Upstream of
tet(W) is a transposase gene, which is cotranscribed in tandem.
Transposases have been found to be involved in the horizontal
gene transfer of genetic elements among bacteria, but to date
there is no evidence that tet(W) in B. animalis subsp. lactis is
transmissible.
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